Prospects in the management of patients with follicular lymphoma beyond first-line therapy | Haematologica
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies | PLOS ONE
![Current Oncology | Free Full-Text | Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done Current Oncology | Free Full-Text | Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done](https://pub.mdpi-res.com/curroncol/curroncol-29-00506/article_deploy/html/images/curroncol-29-00506-g001.png?1662627856)
Current Oncology | Free Full-Text | Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done
![Second- and third-line treatment strategies in multiple myeloma: a referral-center experience | Blood Cancer Journal Second- and third-line treatment strategies in multiple myeloma: a referral-center experience | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00757-8/MediaObjects/41408_2022_757_Figa_HTML.png)
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience | Blood Cancer Journal
ecancer on Twitter: "#Chemotherapy is often the first line treatment for metastatic #breastcancer. However, patients with HR+ breast cancer may also respond well to endocrine therapy. Follow the decision tree to learn
Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomes | PLOS ONE
![Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - ScienceDirect Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827820304700-gr1.jpg)
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - ScienceDirect
![Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice - ScienceDirect Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1533002818304717-gr2.jpg)
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice - ScienceDirect
![Third-Line Treatment for Metastatic Colorectal Cancer | LONSURF® (trifluridine and tipiracil) tablets Third-Line Treatment for Metastatic Colorectal Cancer | LONSURF® (trifluridine and tipiracil) tablets](https://www.lonsurfhcp.com/Content/img/mCRC/mcrc-patients-third-line-treatment.png)
Third-Line Treatment for Metastatic Colorectal Cancer | LONSURF® (trifluridine and tipiracil) tablets
![Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse | Blood Cancer Journal Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-019-0209-5/MediaObjects/41408_2019_209_Fig1_HTML.png)
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse | Blood Cancer Journal
![Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study - The Lancet HIV Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study - The Lancet HIV](https://www.thelancet.com/cms/attachment/3fc97607-2c9a-466f-834d-a4ebfad48cf2/gr1.jpg)
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study - The Lancet HIV
![National patterns of filled prescriptions and third line treatment use for privately insured women with overactive bladder - Mayo Clinic National patterns of filled prescriptions and third line treatment use for privately insured women with overactive bladder - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2021/05/18/17/16/overactive-diagram-fig1-767x535.jpg)
National patterns of filled prescriptions and third line treatment use for privately insured women with overactive bladder - Mayo Clinic
![First-, second- and third-line lung cancer treatment patterns and associated costs in a US healthcare claims database | Lung Cancer Management First-, second- and third-line lung cancer treatment patterns and associated costs in a US healthcare claims database | Lung Cancer Management](https://www.futuremedicine.com/cms/10.2217/lmt.15.12/asset/images/medium/figure1.gif)
First-, second- and third-line lung cancer treatment patterns and associated costs in a US healthcare claims database | Lung Cancer Management
![Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - ScienceDirect Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827820304700-gr2.jpg)
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - ScienceDirect
![Frontiers | Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer Frontiers | Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer](https://www.frontiersin.org/files/Articles/97487/fonc-04-00256-HTML/image_m/fonc-04-00256-g001.jpg)
Frontiers | Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
![Third-line treatment of HER2-positive advanced breast cancer: From no standard to a Pandora's box - ScienceDirect Third-line treatment of HER2-positive advanced breast cancer: From no standard to a Pandora's box - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X20302067-gr1.jpg)